Oxford BioDynamics (LON:OBD) Stock Price Crosses Below 50-Day Moving Average – Here’s Why

Oxford BioDynamics Plc (LON:OBD) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 0.13 and traded as low as GBX 0.12. Oxford BioDynamics shares last traded at GBX 0.12, with a volume of 1,886,741 shares.

Oxford BioDynamics Price Performance

The stock has a market capitalization of £5.15 million, a price-to-earnings ratio of -0.60 and a beta of 0.42. The company has a current ratio of 2.01, a quick ratio of 2.80 and a debt-to-equity ratio of 131.61. The stock has a 50-day moving average price of GBX 0.13 and a 200 day moving average price of GBX 0.19.

Oxford BioDynamics (LON:OBD) last issued its quarterly earnings results on Tuesday, June 30th. The biotechnology company reported GBX (0.10) EPS for the quarter. Oxford BioDynamics had a negative return on equity of 451.74% and a negative net margin of 825.61%.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.